These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23606545)

  • 21. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
    Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH-Sensitive Nanoparticles Codelivering Docetaxel and Dihydroartemisinin Effectively Treat Breast Cancer by Enhancing Reactive Oxidative Species-Mediated Mitochondrial Apoptosis.
    Tao J; Diao L; Chen F; Shen A; Wang S; Jin H; Cai D; Hu Y
    Mol Pharm; 2021 Jan; 18(1):74-86. PubMed ID: 33084332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment.
    Pawar VK; Gupta S; Singh Y; Meher JG; Sharma K; Singh P; Gupta A; Bora HK; Chaurasia M; Chourasia MK
    J Biomed Nanotechnol; 2015 Oct; 11(10):1747-63. PubMed ID: 26502638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biocompatibility, efficacy and biodistribution of Gelucire-stabilized nanoparticles engineered for docetaxel delivery.
    Wehrung D; Geldenhuys WJ; Bi L; Oyewumi MO
    J Nanosci Nanotechnol; 2012 Mar; 12(3):2901-11. PubMed ID: 22755140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution.
    Ma M; Hao Y; Liu N; Yin Z; Wang L; Liang X; Zhang X
    Int J Nanomedicine; 2012; 7():3389-98. PubMed ID: 22848167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
    Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity.
    Yuan Q; Han J; Cong W; Ge Y; Ma D; Dai Z; Li Y; Bi X
    Int J Nanomedicine; 2014; 9():4829-46. PubMed ID: 25378924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
    Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
    J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
    Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
    Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy.
    Balakrishnan P; Song CK; Jahn A; Cho HJ
    Pharm Res; 2016 Jan; 33(1):206-16. PubMed ID: 26337769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment.
    Pan J; Liu Y; Feng SS
    Nanomedicine (Lond); 2010 Apr; 5(3):347-60. PubMed ID: 20394529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
    Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
    Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.
    Chen L; Sha X; Jiang X; Chen Y; Ren Q; Fang X
    Int J Nanomedicine; 2013; 8():73-84. PubMed ID: 23319859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles with Optimal Ratiometric Co-Delivery of Docetaxel with Gambogic Acid for Treatment of Multidrug-Resistant Breast Cancer.
    Xu Y; Wang C; Ding Y; Wang Y; Liu K; Tian Y; Gao M; Li Z; Zhang J; Li L
    J Biomed Nanotechnol; 2016 Sep; 12(9):1774-81. PubMed ID: 29345888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
    Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
    Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway.
    Li J; Zhang J; Wang Y; Liang X; Wusiman Z; Yin Y; Shen Q
    Int J Pharm; 2017 May; 523(1):300-309. PubMed ID: 28336457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.